OBSOLETE: Infantile non-syndromic cataract

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:217052
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Infantile non-syndromic cataract (Orphanet code 217052) is an obsolete clinical entity that was previously used to describe congenital or early-onset lens opacities (cataracts) occurring in infants without associated systemic features (i.e., not part of a broader genetic syndrome). This condition has been reclassified and merged into broader categories of isolated or non-syndromic congenital cataracts within the Orphanet classification system. Non-syndromic congenital cataracts affect the lens of the eye, leading to partial or complete opacification that can impair vision development during a critical period of visual maturation. If left untreated, significant cataracts in infancy can result in amblyopia (lazy eye) and permanent visual impairment. Congenital cataracts can present in various morphological forms, including nuclear, lamellar, cortical, posterior polar, or total cataracts. The condition may be unilateral or bilateral. Isolated (non-syndromic) congenital cataracts can be inherited in autosomal dominant, autosomal recessive, or X-linked patterns, depending on the specific genetic cause. Numerous genes have been implicated, including those encoding crystallins (e.g., CRYAA, CRYBB2, CRYGD), connexins (e.g., GJA3, GJA8), and other lens-related proteins. Treatment typically involves surgical removal of the opacified lens, often followed by optical correction with intraocular lens implantation, contact lenses, or glasses, along with amblyopia therapy. Early intervention is critical to optimize visual outcomes. Because this Orphanet entry is now obsolete, patients and clinicians should refer to the current classification of non-syndromic congenital cataracts for up-to-date information.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2014

HEMANGEOL: FDA approved

Treatment of proliferating infantile hemangioma requiring systemic therapy.

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Infantile non-syndromic cataract.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Infantile non-syndromic cataract at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Infantile non-syndromic cataract community →

No specialists are currently listed for OBSOLETE: Infantile non-syndromic cataract.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Infantile non-syndromic cataract.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Infantile non-syndromic cataractForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Infantile non-syndromic cataract.

Start the conversation →

Latest news about OBSOLETE: Infantile non-syndromic cataract

No recent news articles for OBSOLETE: Infantile non-syndromic cataract.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Infantile non-syndromic cataract

What is OBSOLETE: Infantile non-syndromic cataract?

Infantile non-syndromic cataract (Orphanet code 217052) is an obsolete clinical entity that was previously used to describe congenital or early-onset lens opacities (cataracts) occurring in infants without associated systemic features (i.e., not part of a broader genetic syndrome). This condition has been reclassified and merged into broader categories of isolated or non-syndromic congenital cataracts within the Orphanet classification system. Non-syndromic congenital cataracts affect the lens of the eye, leading to partial or complete opacification that can impair vision development during a

At what age does OBSOLETE: Infantile non-syndromic cataract typically begin?

Typical onset of OBSOLETE: Infantile non-syndromic cataract is infantile. Age of onset can vary across affected individuals.